UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 3, 2021
Accession Number: 0001640334-21-000462
Submission Type: POS AM
CIK: 0001348362
Company Name: Lexaria Bioscience Corp.
File Number: 333-238915